These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 25208755)

  • 21. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
    Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors of acute rejection in sensitized kidney transplant recipients].
    Huang XE; Fan LP; Li LY; Zhao M; Xia SS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1188-91. PubMed ID: 15485797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
    Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
    Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
    Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
    Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine gene polymorphisms in renal transplant recipients.
    Azarpira N; Aghdaie MH; Geramizadeh B; Behzadi S; Nikeghbalian S; Sagheb F; Rahsaz M; Behzad-Behbahanie A; Ayatollahi M; Darai M; Azarpira MR; Banihashemie M; Tabei SZ
    Exp Clin Transplant; 2006 Dec; 4(2):528-31. PubMed ID: 17238853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine polymorphisms and risk of infection after kidney transplantation.
    Rodrigo E; Sánchez-Velasco P; Ruiz JC; Fernández-Fresnedo G; López-Hoyos M; Piñera C; Palomar R; Gómez-Alamillo C; González-Cotorruelo J; Leyba-Cobián F; Arias M
    Transplant Proc; 2007 Sep; 39(7):2219-21. PubMed ID: 17889143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of polymorphisms in the promoter regions of TNF-α (-308) with susceptibility to hepatitis E virus and TNF-α (-1031) and IFN-γ (+874) genes with clinical outcome of hepatitis E infection in India.
    Mishra N; Arankalle VA
    J Hepatol; 2011 Dec; 55(6):1227-34. PubMed ID: 21703188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. -174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period.
    Kocierz M; Siekiera U; Kolonko A; Karkoszka H; Chudek J; Cierpka L; Wiȩcek A
    Tissue Antigens; 2011 Apr; 77(4):283-90. PubMed ID: 21388350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation.
    Asderakis A; Sankaran D; Dyer P; Johnson RW; Pravica V; Sinnott PJ; Roberts I; Hutchinson IV
    Transplantation; 2001 Mar; 71(5):674-7. PubMed ID: 11292301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
    Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S; Collins M; Kenny C; Ryan E; Keane CO; Crowe J
    J Med Virol; 2003 Oct; 71(2):212-8. PubMed ID: 12938195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.
    Hoffmann TW; Halimi JM; Büchler M; Velge-Roussel F; Goudeau A; Al Najjar A; Boulanger MD; Houssaini TS; Marliere JF; Lebranchu Y; Baron C
    Transplantation; 2008 May; 85(10):1406-11. PubMed ID: 18497679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
    Gendzekhadze K; Rivas-Vetencourt P; Montano RF
    Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.